CHLORTHALIDONE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Chlorthalidone, and when can generic versions of Chlorthalidone launch?
Chlorthalidone is a drug marketed by Abbott, Ajanta Pharma Ltd, Alembic, Alkem Labs Ltd, Amneal Pharms Co, Ani Pharms, Appco, Ascot, Barr Labs Inc, Chartwell Rx, Cosette, Dava Pharms Inc, Inventia, Ivax Pharms, Kv Pharm, Mankind Pharma, Mutual Pharm, Mylan, Novast Labs, Pharmobedient, Pioneer Pharms, Purepac Pharm, Sandoz, Sun Pharm Industries, Sunny, Superpharm, Umedica, Unichem, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, and Zydus Pharms. and is included in fifty-eight NDAs.
The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Chlorthalidone
A generic version of CHLORTHALIDONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CHLORTHALIDONE?
- What are the global sales for CHLORTHALIDONE?
- What is Average Wholesale Price for CHLORTHALIDONE?
Summary for CHLORTHALIDONE
| US Patents: | 0 |
| Applicants: | 33 |
| NDAs: | 58 |
| Finished Product Suppliers / Packagers: | 35 |
| Raw Ingredient (Bulk) Api Vendors: | 106 |
| Clinical Trials: | 66 |
| Patent Applications: | 4,029 |
| Drug Prices: | Drug price information for CHLORTHALIDONE |
| Drug Sales Revenues: | Drug sales revenues for CHLORTHALIDONE |
| DailyMed Link: | CHLORTHALIDONE at DailyMed |
See drug prices for CHLORTHALIDONE
Recent Clinical Trials for CHLORTHALIDONE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Bern | Phase 2 |
| Insel Gruppe AG, University Hospital Bern | Phase 2 |
| Jessa Hospital | Phase 4 |
Pharmacology for CHLORTHALIDONE
| Drug Class | Thiazide-like Diuretic |
| Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for CHLORTHALIDONE
US Patents and Regulatory Information for CHLORTHALIDONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 207813-001 | May 10, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novast Labs | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 206904-001 | Mar 30, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Kv Pharm | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 087312-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 087118-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
